1
项与 HBc-HBs/AS01B-4 vaccine(GlaxoSmithKline) 相关的临床试验A first-time-in Human (FTIH), Phase I/II, Randomized, Multi-centric, Single-blind, Controlled Dose-escalation Study to Evaluate the Reactogenicity, Safety, Immunogenicity and Efficacy of GSK Biologicals' HBV Viral Vector Vaccines Given in a Prime-boost Schedule With Sequential or Co-administration of Adjuvanted Proteins Therapeutic Vaccine (GSK3528869A) in Chronic Hepatitis B Patients (18-65 Years Old) Well Controlled Under Nucleo(s)Tide Analogue (NA) Therapy
A First-Time-In-Human study on GSK's therapeutic vaccines to evaluate the reactogenicity, safety, immunogenicity and efficacy on reduction of serum HBV surface antigen in HBV suppressed subjects under nucleo(s)tide treatment.
100 项与 HBc-HBs/AS01B-4 vaccine(GlaxoSmithKline) 相关的临床结果
100 项与 HBc-HBs/AS01B-4 vaccine(GlaxoSmithKline) 相关的转化医学
100 项与 HBc-HBs/AS01B-4 vaccine(GlaxoSmithKline) 相关的专利(医药)
100 项与 HBc-HBs/AS01B-4 vaccine(GlaxoSmithKline) 相关的药物交易